The 2016 UN General Assembly Special Session (UNGASS) on drugs was a watershed moment in global drug policy. It created a rare opportunity to reconsider the prevailing international paradigm on drugs and to chart a new direction.
The UNGASS decade in review: Gaps, achievements and paths for reform
The 2016 UN General Assembly Special Session (UNGASS) on drugs was a watershed moment in global drug policy. It created a rare opportunity to reconsider the prevailing international paradigm on drugs and to chart a new direction.
The UNGASS process was notable for the unprecedented involvement of civil society, affected communities, UN entities and human rights experts. It helped place public health, human rights and communities closer to the centre of drug policy-making, and paved the way for better alignment between the UN drug control regime and the wider UN system. The process also generated valuable momentum for new debates and advocacy at the national level.
However, the UNGASS ultimately fell short of introducing genuine reform of the norms and institutions underpinning the international drug control system.
This report examines progress made since the 2016 UNGASS to assess the role of the global drug control regime in shaping change. It draws on UN data and reporting, academic research, contributions from civil society and community organisations, and a dedicated civil society survey conducted among IDPC members and partners. (IDPC – International Drug Policy Consortium, UK, 03.02.2026)